Bacterial Pneumonia

Infectious Disease

11 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
baxdela	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
XACDURO	Innoviva, Inc. (INVA)
XACDURO®	Innoviva, Inc. (INVA)
zerbaxa	Curative Biotechnology Inc (CUBT)
zevtera	Innoviva, Inc. (INVA)
ZEVTERA®	Innoviva, Inc. (INVA)

Phase 3(2)

Drug	Company
ceftazidime-avibactam	NYMOX PHARMACEUTICAL CORP (NYMXF)
meropenem	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 1(1)

Drug	Company
tp-271	TETRAPHASE PHARMACEUTICALS INC (TTPH)

Preclinical(2)

Drug	Company
tp-271	LA JOLLA PHARMACEUTICAL CO (LJPC)
vibativ	SCICLONE PHARMACEUTICALS INC (SCLN)

BioSniper tracks 11 drugs in development for Bacterial Pneumonia across 7 companies.

There are 1 clinical trial targeting Bacterial Pneumonia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.